Myosin Cross-Bridge Dynamics in Patients With Hypertension and Concentric Left Ventricular Remodeling

Background—Hypertension (HTN) causes concentric left ventricular remodeling, defined as an increased relative wall thickness or overt left ventricular hypertrophy, and associated diastolic dysfunction. HTN and concentric remodeling are also common precursors to heart failure with a preserved ejection fraction. It is not known whether the myofilament contributes to diastolic dysfunction in patients with concentric remodeling. Methods and Results—Intraoperative myocardial biopsies were obtained in 15 male patients undergoing coronary bypass grafting, all with normal left ventricular ejection fraction and wall motion. Eight patients had a history of HTN and concentric remodeling. Seven without HTN or remodeling served as controls. Myocardial strips were dissected and demembranated with detergent. Isometric tension was measured and sinusoidal length perturbation analysis performed at sarcomere length 2.2 &mgr;m and pCa 8 to 4.5. Sinusoidal analysis provides estimates of cross-bridge dynamics, including rate constants of attachment and detachment and cross-bridge attachment time. The normalized isometric tension–pCa relation was similar in HTN and controls. However, cross-bridge attachment time was significantly prolonged at submaximal [Ca2+] (pCa ≥6.5) in HTN patients. Analysis of protein phosphorylation revealed ≈25% reduction in phosphorylation of troponin I in HTN patients (P<0.05). Conclusions—Compared with controls, patients with HTN and concentric remodeling display prolonged cross-bridge attachment time at submaximal [Ca2+] without a change in the tension–pCa relation. Prolonged cross-bridge attachment time implicates altered cross-bridge dynamics as a cause of slowed relaxation in these patients. This finding was associated with reduced phosphorylation of troponin I, suggesting decreased phosphorylation of protein kinase A/G sites as a mechanism.

[1]  R. McKelvie,et al.  Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction , 2011, Circulation.

[2]  Y. Wang,et al.  Roles for cardiac MyBP-C in maintaining myofilament lattice rigidity and prolonging myosin cross-bridge lifetime. , 2011, Biophysical journal.

[3]  M. LeWinter,et al.  Tachycardia-induced diastolic dysfunction and resting tone in myocardium from patients with a normal ejection fraction. , 2011, Journal of the American College of Cardiology.

[4]  M. Zile,et al.  Plasma Biomarkers That Reflect Determinants of Matrix Composition Identify the Presence of Left Ventricular Hypertrophy and Diastolic Heart Failure , 2011, Circulation. Heart failure.

[5]  M. Mulvany,et al.  Disproportionally impaired microvascular structure in essential hypertension , 2011, Journal of hypertension.

[6]  C. Tschöpe,et al.  Diastolic tissue Doppler indexes correlate with the degree of collagen expression and cross-linking in heart failure and normal ejection fraction. , 2011, Journal of the American College of Cardiology.

[7]  Y. Wang,et al.  Effects of Cardiac Myosin Isoform Variation on Myofilament Function and Crossbridge Kinetics in Transgenic Rabbits , 2009, Circulation. Heart failure.

[8]  S. Palaniyandi,et al.  Protein kinase C in heart failure: a therapeutic target? , 2008, Cardiovascular research.

[9]  P. Powers,et al.  Acceleration of Crossbridge Kinetics by Protein Kinase A Phosphorylation of Cardiac Myosin Binding Protein C Modulates Cardiac Function , 2008, Circulation research.

[10]  P. Rosevear,et al.  The unique functions of cardiac troponin I in the control of cardiac muscle contraction and relaxation. , 2008, Biochemical and biophysical research communications.

[11]  L. Carrier,et al.  Cardiac Myosin-Binding Protein C Is Required for Complete Relaxation in Intact Myocytes , 2007, Circulation research.

[12]  R. Moss,et al.  Differential Roles of Cardiac Myosin-Binding Protein C and Cardiac Troponin I in the Myofibrillar Force Responses to Protein Kinase A Phosphorylation , 2007, Circulation research.

[13]  D. Maughan,et al.  Two-state model of acto-myosin attachment-detachment predicts C-process of sinusoidal analysis. , 2007, Biophysical journal.

[14]  R. Marquetant,et al.  Protein kinase C in the human heart: differential regulation of the isoforms in aortic stenosis or dilated cardiomyopathy , 2007, Molecular and Cellular Biochemistry.

[15]  D. Kass,et al.  Cardiac Structure and Ventricular–Vascular Function in Persons With Heart Failure and Preserved Ejection Fraction From Olmsted County, Minnesota , 2007, Circulation.

[16]  Serguei V. S. Pakhomov,et al.  Systolic and diastolic heart failure in the community. , 2006, JAMA.

[17]  P. D. de Tombe,et al.  Left ventricular myofilament dysfunction in rat experimental hypertrophy and congestive heart failure. , 2006, American journal of physiology. Heart and circulatory physiology.

[18]  V. Roger,et al.  Trends in prevalence and outcome of heart failure with preserved ejection fraction. , 2006, The New England journal of medicine.

[19]  Peter C Austin,et al.  Outcome of heart failure with preserved ejection fraction in a population-based study. , 2006, The New England journal of medicine.

[20]  G. Vassort,et al.  Length and protein kinase A modulations of myocytes in cardiac myosin binding protein C-deficient mice. , 2006, Cardiovascular research.

[21]  D. Maughan,et al.  Acto-myosin crossbridge kinetics in humans with coronary artery disease: influence of sex and diabetes mellitus. , 2005, Journal of molecular and cellular cardiology.

[22]  Ajay M Shah,et al.  Regulation of cardiac contractile function by troponin I phosphorylation. , 2005, Cardiovascular research.

[23]  M. Redfield,et al.  Epidemiology of diastolic heart failure. , 2005, Progress in cardiovascular diseases.

[24]  Chen Xu,et al.  Single particle analysis of relaxed and activated muscle thin filaments. , 2005, Journal of molecular biology.

[25]  L. Leinwand,et al.  Expression of cardiac troponin T with COOH-terminal truncation accelerates cross-bridge interaction kinetics in mouse myocardium. , 2004, American journal of physiology. Heart and circulatory physiology.

[26]  D. Zawieja,et al.  Roles of phosphorylation of myosin binding protein‐C and troponin I in mouse cardiac muscle twitch dynamics , 2004, The Journal of physiology.

[27]  K. Swedberg,et al.  Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. , 2004, Journal of the American College of Cardiology.

[28]  C. Brilla,et al.  Effects of ACE Inhibition versus Non-ACE Inhibitor Antihypertensive Treatment on Myocardial Fibrosis in Patients with Arterial Hypertension , 2003, Herz.

[29]  A. Kitabatake,et al.  Different coronary blood flow increase in left ventricular hypertrophy due to hypertension compared to hypertrophic cardiomyopathy at elevated heart rate. , 2003, Hypertension research : official journal of the Japanese Society of Hypertension.

[30]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[31]  N. Alpert,et al.  Myosin from failing and non-failing human ventricles exhibit similar contractile properties. , 2003, Journal of molecular and cellular cardiology.

[32]  N. Alpert,et al.  Alterations of Myocardial Dynamic Stiffness Implicating Abnormal Crossbridge Function in Human Mitral Regurgitation Heart Failure , 2002, Circulation research.

[33]  J. Leiden,et al.  Phosphorylation of Troponin I by Protein Kinase A Accelerates Relaxation and Crossbridge Cycle Kinetics in Mouse Ventricular Muscle , 2001, Circulation research.

[34]  P. Weidmann,et al.  Diastolic dysfunction precedes myocardial hypertrophy in the development of hypertension. , 2001, American journal of hypertension.

[35]  C. Seiler,et al.  Relaxation in hypertrophic cardiomyopathy and hypertensive heart disease: relations between hypertrophy and diastolic function , 2000, Heart.

[36]  R. Mentzer,et al.  Myofibrillar calcium sensitivity of isometric tension is increased in human dilated cardiomyopathies: role of altered beta-adrenergically mediated protein phosphorylation. , 1996, The Journal of clinical investigation.

[37]  K. MacLeod,et al.  Effect of hypertrophy on mechanisms of relaxation in isolated cardiac myocytes from guinea pig. , 1994, The American journal of physiology.

[38]  W. Grossman,et al.  Ca2+ handling and myofibrillar Ca2+ sensitivity in ferret cardiac myocytes with pressure-overload hypertrophy. , 1994, The American journal of physiology.

[39]  M Kawai,et al.  Crossbridge scheme and the kinetic constants of elementary steps deduced from chemically skinned papillary and trabecular muscles of the ferret. , 1993, Circulation research.

[40]  N. Alpert,et al.  Protection of Human Left Ventricular Myocardium From Cutting Injury With 2,3 -Butanedione Monoxime , 1989, Circulation research.

[41]  R. Godt,et al.  Influence of temperature upon contractile activation and isometric force production in mechanically skinned muscle fibers of the frog , 1982, The Journal of general physiology.

[42]  Masataka Kawai,et al.  Sinusoidal analysis: a high resolution method for correlating biochemical reactions with physiological processes in activated skeletal muscles of rabbit, frog and crayfish , 1980, Journal of Muscle Research & Cell Motility.

[43]  Steven B Marston,et al.  Troponin phosphorylation and regulatory function in human heart muscle: dephosphorylation of Ser23/24 on troponin I could account for the contractile defect in end-stage heart failure. , 2007, Journal of molecular and cellular cardiology.

[44]  M. LeWinter,et al.  Protein kinase A mediated modulation of acto-myosin kinetics. , 2005, Journal of molecular and cellular cardiology.

[45]  Z. Papp,et al.  Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins. , 2003, Cardiovascular research.

[46]  J. Moore,et al.  Work production and work absorption in muscle strips from vertebrate cardiac and insect flight muscle fibers. , 1998, Advances in experimental medicine and biology.